1. Startpage

Search

Current filters:




Use filters to refine the search results.

Start a new search
Results 1-10 of 35 (Search time: 0.009 seconds).
Item hits:
PreviewIssue dateOnline publication dateTitleAuthor(s)
59415.pdf.jpg201911-Nov-2019Cardiovascular risk categories in patients with nonalcoholic fatty liver disease and the role of low-density lipoprotein cholesterolLabenz, Christian; Prochaska, Jürgen H.; Huber, Yvonne; Nagel, Michael; Straub, Beate; Wild, Philipp; Galle, Peter R.; Schattenberg, Jörn
58508.pdf.jpg201817-Oct-2018The immune contexture of hepatocellular carcinoma predicts clinical outcomeFoerster, Friedrich; Hess, Moritz; Gerhold-Ay, Aslihan; Marquardt, Jens; Becker, Diana; Galle, Peter R.; Schuppan, Detlef; Binder, Harald; Bockamp, Ernesto
58506.pdf.jpg201817-Oct-2018Validation of the SNACOR clinical scoring system after transarterial chemoembolisation in patients with hepatocellular carcinomaMähringer-Kunz, Aline; Weinmann, Arndt; Schmidtmann, Irene; Koch, Sandra; Schotten, Sebastian; Pinto dos Santos, Daniel; Pitton, Michael B.; Düber, Christoph; Galle, Peter R.; Klöckner, Roman
hahn_felix-risk_stratific-20201015161959392.pdf.jpg202016-Oct-2020Risk stratification in advanced biliary tract cancer : validation of the A.L.A.N. scoreMüller, Lukas; Mähringer-Kunz, Aline; Jungmann, Florian; Tanyildizi, Yasemin; Bartsch, Fabian; Czauderna, Carolin; Düber, Christoph; Galle, Peter R.; Weinmann, Arndt; Kloeckner, Roman; Hahn, Felix
diabetic_liver_injury_from_st-20220913193459567.pdf.jpg201314-Sep-2022Diabetic liver injury from streptozotocin is regulated through the caspase-8 homolog cFLIP involving activation of JNK2 and intrahepatic immunocompetent cellsKohl, Tobias; Gehrke, Nadine; Schad, Arno; Nagel, Michael; Wörns, Marcus-Alexander; Sprinzl, Martin; Zimmermann, Tim; He, You Wen; Galle, Peter R.; Schuchmann, Marcus; Schattenberg, Jörn
efficacy_and_safety_of_a_conv-20220714111608576.pdf.jpg201515-Jul-2022Efficacy and safety of a conversion from the original tacrolimus and mycophenolate mofetil to the generics Tacpan® and Mowel® after liver transplantationVollmar, Johanna; Bellmann, Maren Christina; Darstein, Felix; Hoppe-Lotichius, Maria; Mittler, Jens; Heise, Michael; Rüttger, Bernd; Weyer, Veronika; Zimmermann, Anca; Lang, Hauke; Galle, Peter R.; Zimmermann, Tim
michel_maurice-the_role_of_p5-20210723162504858.pdf.jpg20212-Aug-2021The role of p53 dysfunction in colorectal cancer and its implication for therapyMichel, Maurice; Kaps, Leonard; Maderer, Annett; Galle, Peter R.; Moehler, Markus
59893.pdf.jpg202030-Jun-2020Risk prediction in intrahepatic cholangiocarcinoma : direct comparison of the MEGNA score and the 8th edition of the UICC/AJCC cancer staging systemHahn, Felix; Müller, Lukas; Mähringer-Kunz, Aline; Schotten, Sebastian; Düber, Christoph; Hinrichs, Jan B.; Maschke, Sabine K.; Galle, Peter R.; Bartsch, Fabian; Lang, Hauke; Weinmann, Arndt; Kloeckner, Roman
kaps_leonard-treatment_of_c-20210104145006284.pdf.jpg202020-Jan-2021Treatment of cytokine storm syndrome with IL‐1 receptor antagonist anakinra in a patient with ARDS caused by COVID‐19 infection : a case reportKaps, Leonard; Labenz, Christian; Grimm, Daniel; Schwarting, Andreas; Galle, Peter R.; Schreiner, Oliver
kloeckner_roman-survival_predi-20210416121106975.pdf.jpg20203-May-2021Survival prediction for patients with non-resectable intrahepatic cholangiocarcinoma undergoing chemotherapy : a retrospective analysis comparing the tumor marker CA 19-9 with cross-sectional imagingHahn, Felix; Müller, Lukas; Jungmann, Florian; Mähringer‑Kunz, Aline; Tanyildizi, Yasemin; Düber, Christoph; Galle, Peter R.; Weinmann, Arndt; Kloeckner, Roman

Refine search results